METHODS OF IMMORTALIZING PRIMARY RESTING T CELLS BY CRISPR/DCAS9-BASED EPIGENETIC MODIFIERS AND TRANSCRIPTIONAL ACTIVATORS
US20260092294A1 · Application publication visible
Patent Applicant View
UNIV CITY HONG KONG [HK]
Explore source-linked longevity patent families and topic connections associated with the applicant name UNIV CITY HONG KONG [HK].
Applicant activity
1 source-linked patent families
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.